Vera Therapeutics, Inc. (VERA) Free cash flow 2020–2025
Vera Therapeutics, Inc. (VERA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$241.7MFY2025 · since FY2020: -$34.9M → -$241.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$241.7M | -78.2% |
| FY2024 | -$135.7M | -47.1% |
| FY2023 | -$92.2M | -36.3% |
| FY2022 | -$67.7M | -185.4% |
| FY2021 | -$23.7M | +32.1% |
| FY2020 | -$34.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice